eLife · 2021 · 33 citations · 35 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsImmunoregulationMolecular VirologyAntiviral ImmunityEffector Function ModulationHost-virus InteractionsViral Immune EvasionViral InfectionsViral PathogenesisAntibody Effector FunctionsAntibody Effector MechanismsAntibody-dependent Cellular CytotoxicityFc ReceptorsHost Immune ControlProtein Conformational ChangesViral Evasion MechanismsViral Glycoproteins
Human cytomegalovirus (HCMV) is endowed with multiple highly sophisticated immune evasion strategies. This includes the evasion from antibody mediated immune control by counteracting host Fc-gamma receptor (FcγR) mediated immune control mechanisms such as antibody-dependent cellular cytotoxicity (ADCC). We have previously shown that HCMV avoids FcγR activation by concomitant expression of the viral Fc-gamma-binding glycoproteins (vFcγRs) gp34 and gp68. We now show that gp34 and gp68 bind IgG simultaneously at topologically different Fcγ sites and achieve efficient antagonization of host FcγR activation by distinct but synergizing mechanisms. While gp34 enhances immune complex internalization, gp68 acts as inhibitor of host FcγR binding to immune complexes. In doing so, gp68 induces Fcγ accessibility to gp34 and simultaneously limits host FcγR recognition. The synergy of gp34 and gp68 is compelled by the interfering influence of excessive non-immune IgG ligands and highlights conformational changes within the IgG globular chains critical for antibody effector function.
35
Pierre Bruhns, Bruno Iannascoli, Patrick England et al. · Blood · 2008 · 1.5K citations · Full text
Robert L. Shields, Angela K. Namenuk, Kyu Hong et al. · Journal of Biological Chemistry · 2001 · 1.2K citations · Full text
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell, Lars Hangartner, Meredith Hunter et al. · Nature · 2007 · 899 citations